BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boertien TM, Drent ML, Booij J, Majoie CBLM, Stokkel MPM, Hoogmoed J, Pereira A, Biermasz NR, Simsek S, Groote Veldman R, Tanck MWT, Fliers E, Bisschop PH. The GALANT trial: study protocol of a randomised placebo-controlled trial in patients with a 68 Ga -DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma on the effect of lan reotide on t umour size. BMJ Open 2020;10:e038250. [PMID: 32792446 DOI: 10.1136/bmjopen-2020-038250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Palmisciano P, Watanabe G, Conching A, Ogasawara C, Ferini G, Bin-Alamer O, Haider AS, Sabini MG, Cuttone G, Cosentino S, Ippolito M, Umana GE. The Role of [68Ga]Ga-DOTA-SSTR PET Radiotracers in Brain Tumors: A Systematic Review of the Literature and Ongoing Clinical Trials. Cancers (Basel) 2022;14:2925. [PMID: 35740591 DOI: 10.3390/cancers14122925] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lybik N, Wale DJ, Wong KK, Liao E, Viglianti BL. 68Ga-DOTATATE PET/CT Imaging of Refractory Pituitary Macroadenoma Invading the Orbit. Clin Nucl Med 2021;46:505-6. [PMID: 33782291 DOI: 10.1097/RLU.0000000000003589] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]